Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ · Healthcare

Total Assets Cash on Hand Long Term Debt Total Liabilities Shareholder Equity

Vertex Pharmaceuticals Incorporated annual/quarterly total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

Vertex Pharmaceuticals Incorporated total liabilities for the quarter ending December 31, 2025 were 6.98B, a 13.94% increase year-over-year.
Vertex Pharmaceuticals Incorporated total liabilities for 2025 were 6.98B, a 13.94% increase from 2024.
Vertex Pharmaceuticals Incorporated total liabilities for 2024 were 6.12B, a 18.91% increase from 2023.
Vertex Pharmaceuticals Incorporated total liabilities for 2023 were 5.15B, a 21.51% increase from 2022.
Vertex Pharmaceuticals Incorporated total liabilities for 2022 were 4.24B.

Total Liabilities

QUARTERLY · $B

YOY QUARTERLY GROWTH · %

Vertex Pharmaceuticals Incorporated Annual Total Liabilities (Millions of US $)
2025	$6,977
2024	$6,124
2023	$5,150
2022	$4,238
2021	$3,333
2020	$3,065
2019	$2,233
2018	$1,811
2017	$1,504
2016	$1,559
2015	$1,405
2014	$1,238
2013	$963
2012	$1,525
2011	$1,239

Vertex Pharmaceuticals Incorporated Quarterly Total Liabilities (Millions of US $)
2025-12-31	$6,977
2024-12-31	$6,124
2023-12-31	$5,150
2022-12-31	$4,238
2021-12-31	$3,333
2020-12-31	$3,065
2019-12-31	$2,233
2018-12-31	$1,811
2017-12-31	$1,504
2016-12-31	$1,559
2015-12-31	$1,405
2014-12-31	$1,238
2013-12-31	$963
2012-12-31	$1,525
2011-12-31	$1,239
2010-12-31	$1,221
2009-12-31	$859

Vertex Pharmaceuticals Inc. Total Liabilities — FAQ

Vertex Pharmaceuticals Inc. (VRTX) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VRTX's total liabilities history?

The chart and table above show Vertex Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.